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Abstract Recent advances in nucleic acids engineering introduced several RNA-based regulatory components for
synthetic gene circuits, expanding the toolsets to engineer organisms. In this work, we designed genetic circuits
implementing an RNA aptamer previously described to have the capability of binding to the T7 RNA polymerase
and inhibiting its activity in vitro. Using in vitro transcription assays, we first demonstrated the utility of the
RNA aptamer in combination with programmable synthetic transcription networks. As a step to quickly assess
the feasibility of aptamer functions in vivo, a cell-free expression system was used as a breadboard to emulate the
in vivo conditions of E. coli. We tested the aptamer and its three sequence variants in the cell-free expression
system, verifying the aptamer functionality in the cell-free testbed. In vivo expression of aptamer and its variants
demonstrated control over GFP expression driven by T7 RNA polymerase with different response curves, indicating
its ability to serve as building blocks for both logic circuits and transcriptional cascades. This work elucidates the
potential of RNA-based regulators for cell programming with improved controllability leveraging the fast production
and degradation time scales of RNA molecules.
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Introduction
Synthetic biology provides an engineering approach
to the field of biology to (re)design tools and biological
systems that can open up new possibilities in biotechnol-
ogy and medicine [1, 2, 3, 4, 5]. To achieve this goal,
such de novo biological systems need to be easily engi-
neerable, ideally through utilizing molecular mechanisms
that work much as the programming codes. The first syn-
thetic gene networks, the toggle switch [6] and the repres-
silator [7], demonstrated the feasibility of programming
computational tasks in living cells. Recent advances in
synthetic biology further expanded the set of programs in
biological organisms with novel functions including logic
gates [8, 9, 10, 11, 12], cell classifiers [13], and analog
signal processors [14]. Most synthetic gene circuits con-
structed to date relied on well-characterized protein com-
ponents, which results in a challenge for scaling up syn-
thetic circuitry with predictable dynamical behaviors due
to the idiosyncratic nature of each protein component in-
volved. Recent advances aim to address such limitations
through increasing the number of orthogonal protein reg-
ulators [15] as well as protein regulators that rely on nu-
cleic acids as guiding molecules [16, 17].
To address the component bottleneck in synthetic bi-
ology, RNA structures have also been utilized as impor-
tant tools for programming gene expression inspired by
the naturally occuring nucleic-acid-based regulatory mo-
tifs [18, 19, 20]. By virtue of their predictive interactions
with other nucleic acids, proteins, and small molecules,
many RNA-based regulatory circuits have been investi-
gated and synthesized [21, 22, 23, 24, 25, 26, 27, 28, 29, 30,
31, 32]. Importantly, RNA aptamers possess the molec-
ular recognition properties with specificity and affinity
rivaling protein antibodies for exclusive ligands, allow-
ing these molecules to form a useful set of components
for synthetic circuitry in living cells. RNA aptamers are
typically generated and selected in vitro starting from
large random sequence libraries, and are subsequently op-
timized for high affinity binding to given ligands by a pro-
cess known as SELEX (Systematic Evolution of Ligands
by EXponential enrichment) [33, 34, 35, 36].
In a recent work, Ohuchi and co-workers [37] reported
the in vitro evolution of RNA aptamers against T7 RNA
polymerase (T7 RNAP) through SELEX. Although the
detailed mechanism is not yet fully understood, it was
shown that the RNA aptamers inhibited the association
of T7 RNAP with T7 promoter DNA, thereby inhibit-
ing the activity of RNAP in in vitro transcription assays.
Utilizing the property of this aptamer, we implemented
synthetic logic circuits in an in vitro transcription set-
ting. As a step to quickly assess the aptamer functional-
ity in vivo, a cell-free transcription-translation (TX-TL)
system was employed as a ‘breadboard’ to emulate the
in vivo conditions of E. coli for circuitry testing [38, 39].
Experimental results demonstrated that the T7 RNAP
aptamer showed up to 8- and 5-fold inhibition in TX-TL
system and in E. coli MGZ1 cells, respectively. Due to
the wide-spread usage of T7 RNAP for in vitro and in
vivo applications [40, 41, 42, 43], the T7 RNAP aptamer
can be a useful addition to the regulatory toolkit for in
vitro and in vivo synthetic biology.
Materials and Methods
Circuit construction and use of strains. Plas-
mid pAR1219 was obtained from Sigma-Aldrich. Plas-
mid pTara was provided by Matthew Bennett’s group at
Rice University. The rest of the circuits were constructed
using Gibson assembly [44]. Schematics for plasmids are
shown in the main text and the full sequences and anno-
tations are described in Supplementary Figure S1. Plas-
mids were transformed into strains via chemical transfor-
mation. E. coli MGZ1 strain (MG1655 containing the
LacI- and TetR-overexpressing Z1 cassette) was used for
inducible expression from the TetR-regulated promoter.
Plasmids pdeGFP-T7apt-4A, pdeGFP-T7apt-4G, and
pdeGFP-T7apt-4∆ were derived from the plasmid pdeGFP-
T7apt via round-the-horn site-directed mutagenesis using
5′-phosphorylated primers for subsequent ligation. Plas-
mids containing the T7 RNAP aptamer and variants have
an additional XhoI site between the aptamer and the ter-
minator sequences (the functionality of the T7 RNAP ap-
tamer was not affected by this feature). All of the plasmid
sequences were confirmed by DNA sequencing.
In vitro transcription reaction. The sequence
of all DNA molecules and expected RNA transcript se-
quences were chosen to minimize the occurrence of al-
ternative secondary structures using the DNA and RNA
folding program NUPACK [45]. The DNA and RNA se-
quences used in this study are listed in Supplementary
material. All DNA oligonucleotides were purchased from
Integrated DNA Technologies (USA). The T7 RNA poly-
merase (Cellscript, Madison, WI, USA; #C-AS2607), T3
RNA polymerase (Promega, Madison, WI, USA; #P4024),
10× transcription buffer and thermostable inorganic py-
rophosphatase (New England Biolabs, Ipswich, MA, USA;
#B9012S, #M0296S), NTP (Epicentre, Madison, WI, USA;
#RN02825) were purchased. Malachite green dye was
purchased from Sigma (#M9015). Since pyrophosphatase
is involved in regulating the byproduct inorganic pyrophos-
phate for our transcriptional circuits and is not directly
involved in the dynamics, we do not call it an “essential
enzyme” for the circuit dynamics.
The fluorescence was recorded every minute using a
Fluorolog-3 spectrofluorometer (Jobin Yvon, Edison, NJ,
USA). The excitation and emission for malachite green
fluorescence were at 630 nm and 655 nm. DNA templates
were annealed with 10% (v/v) 10× transcription buffer
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from 90◦C to 20◦C over 1 hour at 5 µM concentrations.
Transcription reactions were prepared by combining the
annealed templates, 7.5 mM of each NTP, 24 mM MgCl2
(to balance salt concentrations due to increased NTP con-
centrations), 10% (v/v) 10× transcription buffer, and
25 µM malachite green dye in a test tube. Transcrip-
tion reactions for spectrofluorometer experiments were
prepared as a total volume of 60 µL in quartz cuvettes and
enzymes (RNAP and PPase) were added and mixed after
the baseline fluorescence was recorded for 10 min. Sam-
ple temperature was maintained at 29◦C using a 4-sample
changer with a temperature-controlled water bath.
Media, chemicals and other reagents. Strains
were grown in LB liquid medium or on agar plates (1.5%
agar), supplemented with carbenicillin (100 µg/ml), and
chloramphenicol (34 µg/ml) as needed. IPTG induction
was at 10 µM unless otherwise noted. Anhydrotetracy-
cline (aTc) induction experiments used different concen-
trations of aTc to achieve different levels of RNA aptamer
expression as described in the figure captions.
Plate reader analysis. For cell-free TX-TL experi-
ments, GFP fluorescence was measured using a filter set
with excitation wavelength at 488 nm and emission wave-
length at 507 nm. All data were obtained using Perkin
Elmer Victor X3 plate reader. Preparation of the cell-free
TX-TL expression system was done according to previ-
ously described protocols [38, 39]. A single batch of E. coli
extract was used consistently throughout the experiments
to prevent variation from batch to batch. Samples were
prepared by combining extract and buffer tubes freshly
thawed from −80◦C, and purified plasmid DNA. Concen-
trations of plasmids pAR1219 and pdeGFP-T7apt and
its variants were 0.8 nM for Figure 2. The concentra-
tions of plasmids pAR1219, pT7-deGFP, and pTet-T7apt
were 0.6 nM for Supplementary Figure S3. The reaction
volume was 10 µL in a 384-well plate (Nunc), and the
number of replicates was two for each reaction. Sample
temperature was maintained at 29◦C.
For in vivo experiments, cells were grown in shaking
liquid culture (LB media with carbenillin and chloram-
phenicol) at 37◦C overnight. Following this, the culture
was diluted 1/200 fold for plate reader measurements.
GFP fluorescence was measured using a monochromater
with excitation wavelength at 485 nm and emission wave-
length at 525 nm in Biotek Synergy H1 plate reader. Flu-
orescence data were normalized by OD600 values. The
culture volume was 200 µL in a 96-well plate (Nunc), and
the number of replicates was three for each condition.
Sample temperature was maintained at 37◦C.
Flow cytometry analysis. Cells were grown in
shaking liquid culture (LB media with carbenillin and
chloramphenicol) at 37◦C overnight. Following this, the
culture was diluted 1/100 fold and grown at 37◦C (LB
media with antibiotics and 1% glucose and aTc) for two
hours. Flow cytometry analysis used a Cell Lab Quanta
SC MPL flow cytometer (Beckman Coulter). GFP was
excited from a 488 nm laser and emission was measured
from 517 nm longpass filter with a PMT setting of 5.0.
For each sample, the GFP values of 50,000 cells were mea-
sured. Cells were then gated for GFP levels above back-
ground (2 a.u.). Data were analyzed using MATLAB and
modal values were determined. The number of replicates
was three for T7apt and the number of replicates were
two for its variants T7apt-4A, T7apt-4G, and T7apt-4∆.
Results
T7 RNAP aptamer for in vitro transcriptional
circuits. First, we aim to demonstrate the utility of T7
RNAP aptamer for in vitro transcriptional circuits. Us-
ing the synthetic transcriptional switch as the regulatory
motif and the aptamer for the chromophore malachite
green (MG) as the output signal, we construct a logic
circuit utilizing the property of T7 RNAP aptamer (Fig-
ure 1A). Among the several variants of T7 RNAP ap-
tamers reported in Ohuchi et al. [37], our first in vitro
assays utilized the aptamer T230-38. In this circuit, the
two RNA polymerases, T3 RNAP and T7 RNAP, to-
gether with DNA activators serve as inputs and the fluo-
rescence of MG aptamer serves as an output. Figure 1B
illustrates the molecular reactions for this synthetic tran-
scriptional circuit. An MG aptamer, MGapt, consists of
a short RNA sequence whose central loop region serves
as the binding pocket for MG. When MG is bound to the
aptamer, it becomes highly fluorescent [46], thereby pro-
viding a convenient, real-time read-out for RNA expres-
sion. Previous in vitro synthetic transcriptional circuits
utilized T7 RNAP [47, 48, 49, 50, 51]. However, since
we aim to characterize an aptamer against T7 RNAP, a
separate enzyme was required to drive the production of
aptamer in order to avoid self-repression. Thus, we first
verified the design principle for synthetic switches utiliz-
ing T3 RNAP using a template encoding MG aptamer
with an incomplete promoter for T3 RNAP, pT3-MGapt;
the production of MGapt was observed upon the addi-
tion of its cognate activator, input A2 (Supplementary
Figure S2A). Utilizing the modular switch architecture
where the output domain is physically separated from
the input and promoter domains, the two templates were
designed to transcribe different RNA outputs and to be
recognized by two different RNA polymerases. (See Sup-
plementary Method for sequences.) The two templates
encoding T7apt and MGapt are hereby denoted as pT3-
T7apt and pT7-MGapt. In this circuit, T3 RNAP recog-
nizes pT3 promoter upon addition of the DNA activator
A2, and induces transcription of T7apt; T7 RNAP recog-
nizes pT7 promoter upon addition of the DNA activator
A1, and induces transcription of MGapt.
Experimentally, we initially included both templates
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Figure 1: Characterization of T7 RNAP aptamer in in vitro transcription circuits. (A) Schematic representation of logic
circuit. The two RNA polymerases and DNA activators serve as inputs and the fluorescence of malachite green aptamer
serves as an ourput. (B) Detailed diagram of synthetic transcription circuit. Promoters pT3 and pT7 are to be recognized
by T3 RNAP and T7 RNAP, respectively, upon addition of the corresponding DNA activator A2 and A1. The switch
templates contain a promoter for RNA polymerase that lacks part of the double-stranded sequence; after addition of a
single stranded DNA activator, the promoter is complete except for a nick, and thus, the transcription efficiency is high.
When the MGapt is expressed, it can binds to the chemical compound malachite green, greatly increasing the fluorescence
signal output. (C) Transcriptional assay of the circuit shown in (B). The two RNA polymerases, T3 RNAP and T7 RNAP,
were added at 10 min, the input DNA activator A1 was introduced at 25 min and the input DNA activator A2 was added
at 45 min as marked by black arrows. The T7apt was efficient in repressing the T7 RNAP activity; about 3-fold decrease
in MGapt signal was observed over 3 hours in the presence of T7apt. ‘Low RNAP’ and ‘High RNAP’ refer to T7 RNAP
concentrations of 20 and 40 nM, respectively.
pT3-T7apt and pT7-MGapt, both T3 and T7 RNAP along
with NTP fuel in the reaction mixture (Figure 1C). No
MGapt expression was observed until the addition of DNA
activator A1; upon the addition of input A1, the tran-
scription of MGapt was immediately observed. Then,
the DNA activator A2 was added for half of the sam-
ples, enabling transcription of T7apt in order to inhibit
T7 RNAP-mediated MGapt expression (Figure 1C). The
‘input A2’ trajectories began to diverge from ‘no input
A2’ trajectories about 10 min after the introduction of
input A2 (Supplementary Figure S2B). The T7apt was ef-
ficient in repressing the T7 RNAP activity; about 3-fold
decrease in MGapt signal was observed in the presence
of T7apt. Further, we tested a modified T7apt termed
T7apt-v2 where two bases comprising stem were switched
and six additional nucleotides were attached at the 3′ end;
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T7apt-v2 was equally efficient in repressing the activity of
T7 RNAP (Supplementary Figure S2C), indicating that
the core structural motif of T7apt is sufficient for its ac-
tivity.
T7 RNAP aptamer functionality in cell-free
TX-TL system. After observing the T7 RNAP aptamer
functionality as a circuit element in the synthetic tran-
scription system, we designed a new circuit for in vivo
application (Figure 2A and Supplementary Figure S3A).
Creating a functional in vivo biocircuit can be a lengthy
process, involving multiple iterations of design, assembly,
and test cycles. Similar challenges may arise for test-
ing novel regulatory mechanisms such as the inhibition
of T7 RNAP through aptamers. To streamline and ex-
pedite the design-build-test cycles, we chose to employ
cell-free TX-TL system; TX-TL system is gaining inter-
est as biomolecular breadboards that take advantage of
shorter assembly and troubleshooting times by conduct-
ing reactions in vitro emulating in vivo conditions [38, 39].
Because requirements for propagating plasmids in vivo
have been removed, fast iterations of the design-assembly-
test cycle of a given circuit is possible using linear DNA
constructs [52]. Further, RNA-based regulatory elements
were recently shown to behave analogously in TX-TL sys-
tem when compared to in vivo, increasing the utility of
this platform [53].
In order to emulate the T7 RNAP aptamer function-
ing in vivo, we assayed the aptamer in the TX-TL sys-
tem. Initially, a three plasmid system was tested (Sup-
plementary Figure S3B): plasmid pAR1219 encoding T7
RNAP under pLac promoter along with LacI constitu-
tively expressed, plasmid pT7-deGFP encoding deGFP
(truncated eGFP to maximize fluorescence output [38])
under pT7 promoter, and plasmid pTet-T7apt encoding
T7 RNAP aptamer under pTet promoter. For a negative
control, two plasmids pAR1219 and pT7-deGFP were in-
troduced in TX-TL system in the absence of IPTG; for
a positive control, the same plasmids were used in the
presence of IPTG; the aptamer functionality was tested
by including all three plasmids at the same concentrations
with IPTG induction. The T7 RNAP aptamer was be-
ing expressed constitutively since TetR repressor was not
present in TX-TL cell extract nor was it encoded on the
plasmids used. Eight-fold reduction of deGFP output was
obtained in the presence of the plasmid expressing the T7
RNAP aptamer (Supplementary Figure S3C).
After the initial verification of T7 RNAP aptamer ac-
tivity in TX-TL, the expression cassettes contained in the
plasmids pT7-deGFP and pTet-T7apt were joined to cre-
ate the plasmid pdeGFP-T7apt (Figure 2A). The repli-
cation origin and antibiotic resistance was also switched
for pdeGFP-T7apt since we aim to investigate its in vivo
activity. Also, mutant variants of the T7 RNAP aptamer
were constructed through site-directed mutagenesis in or-
der to disrupt the conserved sequence domain presum-
ably responsible for T7 RNAP inhibition [37]. The pur-
pose of mutant constructs was two-fold: first, to demon-
strate that T7 RNAP inhibition was not mediated by the
resource exhaustion caused by T7 RNAP aptamer over-
production [54] and second, to verify the functional im-
portance of conserved sequence domain. The nucleotides
28–31 of the T7apt sequence was targeted and replaced
by AAAA, GGGG, or deleted, resulting in three aptamer
variants: pdeGFP-T7apt-4A, pdeGFP-T7apt-4G, and
pdeGFP-T7apt-4∆ (Figure 2C).
These new set of plasmids were tested together with
pAR1219 in the TX-TL expression system (Figure 2B).
The results in the TX-TL system were as expected: the
correct T7 RNAP aptamer (T7apt) showed 8-fold inhi-
bition of the GFP output as in the previous experiment,
whereas the mutant aptamers showed at most 2-fold inhi-
bition, indicating that the core structure of the aptamer
was presumably disrupted as a result of mutation. The
GFP expression was observed after about 1 hr of TX-TL
reaction possibly due to slow production and folding of
T7 RNAP, and soon afterwards the slope of GFP produc-
tion showed clear distinction depending on the identity of
input aptamer used. Notably, the GFP output reduction
was less than 1.5 fold for T7apt-4∆; it is plausible that
overexpression of non-specific RNA species could cause
a small reduction in GFP expression due to resource us-
age [54].
Characterization of T7 RNAP aptamer circuit
in vivo. Encouraged by the activity of T7 RNAP ap-
tamer in the cell-free TX-TL system, we carried out the
characterization of circuit in vivo, utilizing E. coli MGZ1
strain containing constitutively expressed LacI and TetR
to complete the inducible circuit. In this circuit, IPTG
will induce the production of T7 RNAP, hence driving
the expression of deGFP, while aTc will induce the pro-
duction of T7 RNAP aptamer, repressing the expression
of deGFP (Figure 3A). The fluorescence measurement in
plate reader clearly showed that aTc-induced T7apt ex-
pression inhibited the expression of deGFP (Figure 3B).
When T7apt expression was induced with high concentra-
tion of aTc (0.6 µg/mL), 5-fold reduction in the deGFP
output was obtained compared to no aTc. In contrast,
all the mutant variants when induced by the same con-
centration of aTc showed no effect on the deGFP output
(Figure 3B), indicating that the inhibition of T7 RNAP
activity is mediated by the correct aptamer rather than by
cellular stress due to aTc or overexpression of non-specific
RNA species. The fluorescence output decreased once
the cells reach stationary phase, however, the fold-change
was reasonably consistent over time (Supplementary Fig-
ure S4A). Similar results were obtained when E. coli were
grown in LB or LB with 10 µM IPTG although the fold-
change was reduced to 2.5 fold and 2 fold, respectively
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Figure 2: Characterization of T7 RNAP aptamer and its variants in the cell-free TX-TL system. (A) Two-plasmid system
used for aptamer-mediated T7 RNAP inhibition test in the TX-TL cell-free extract. (B) The expression of T7 RNAP was
induced by IPTG and the effect of expression of T7 RNAP aptamer and its variants was tested in TX-TL system. TX-TL
results showed that deGFP expression was approximately 8-fold decreased in the presence of the correct aptamer; the
fluorescence signals were much higher in the presence of modified aptamers indicating disrupted functionality. Negative
control contained only pAR1219 plasmid and positive control contained pAR1219 and pT7-deGFP plasmids. The T7 RNAP
aptamer production was not inhibited by TetR since the cell extract does not contain TetR protein. The fluorescence signal
from deGFP was measured at 5 hrs for the bar plot. (C) The sequence of T7 RNAP aptamer and its variants. Red color
highlights the modified consensus sequence domain.
(Supplementary Figure S4BC).
A more detailed characterization of the circuit was
carried out by testing the response of the circuit to five
different IPTG concentrations ranging from 0 to a 30 µM
and six different aTc concentrations ranging from 0 to 0.6
µg/mL. As shown in Figure 3B, the response is charac-
terized by high GFP expression for high IPTG concentra-
tions and low aTc concentrations. (The response curves
are shown in Supplementary Figure 4D.) At high concen-
tration of IPTG (30 µM), the response was marked by
a constant high GFP expression, possibly due to over-
expression of T7 RNAP beyond that of T7apt. Even
higher concentration of IPTG (100 µM) or aTc (1 µg/mL)
severely impaired the cell growth, and therefore, those
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Figure 3: Characterization of T7 RNAP aptamer and its variants in vivo. E. coli MGZ1 containing constitutively expressed
LacI and TetR was used with two plasmids pAR1219 and pdeGFP-T7apt and its variants as shown in Figure 2A to complete
the inducible circuit. (A) Circuit diagram of T7 RNAP aptamer in vivo. Inputs are small molecules IPTG and aTc and the
output is GFP fluorescence. (B) Plate reader analysis for the response curve of T7 RNAP aptamer and its variants upon
aTc induction. GFP/OD values in LB/1% glucose media were measured at 8 hrs for the plot. Time courses are shown
in Supplementary Figure S4A. The GFP/OD value heat map for different levels of aTc and IPTG inputs is shown on the
right. (C) Flow cytometry analysis for the response curve of T7 RNAP aptamer and its variants upon aTc induction. The
modal values are plotted with the standard deviation of replicate measurements as error bars. One of the replicate GFP
histogram (50,000 events) for T7apt is shown on the right.
regions were not further explored. Overall, the circuit
exhibited a logic gate behavior as shown in Figure 3A.
To explore the circuit response at the individual cell
levels, flow cytometry analysis was performed. Repre-
sentative flow cytometry histograms of GFP output for
different aTc inducer levels clearly showed that GFP out-
put is decreased upon induction of T7apt expression (Fig-
ure 3C). The modal fluorescence values from these his-
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tograms were used to plot the response curves for T7apt
and its variants. The GFP expression showed no depen-
dence on aTc induction levels for mutant T7apt (Fig-
ure 3C and Supplementary Figure S5), confirming the
findings of plate reader analysis.
Discussion
Synthetic gene circuitry and cellular programming open
up new opportunities for biotechnological and medical
applications. With the growing appreciation for RNA
molecules as the key component of genetic regulatory net-
works, efforts to utilize the programmable structure and
function of RNA molecules for synthetic biology have ac-
celerated in the recent past. The demonstration of func-
tional RNA aptamer in living cells provides an alternative
to simple transcription regulatory circuits with transcrip-
tion factors, expanding the toolkit to program cells in
synthetic biology.
In this work, we show that the T7 RNAP aptamer
has the capability of inhibiting the T7 RNAP acivity in
vitro and in vivo with a predictable functional behavior
as a modular component within synthetic network. We
first demonstrated the activity of T7 RNAP aptamer in
in vitro transcription circuits. It is not surprising that
the aptamer would be functional since the assay envi-
ronment is similar to the previous works [37]; however,
we provide a framework for systematic circuit construc-
tion utilizing other RNAP and aptamer components—T3
RNAP and MG aptamer. It remained a question whether
T7 RNAP aptamer can show functionality in vivo given
the complexity of in vivo environment with potentially
strong crosstalk and degradation for aptamer. We uti-
lized a cell-free TX-TL system as a testbed to quickly
assess the feasibility of our approach in vivo. Despite
certain limitations [54], TX-TL system provides a solid
expression platform to connect in vitro activity to in vivo
functionality [38, 52], as recently demonstrated for syn-
thetic RNA circuitry [53]. We used equal concentrations
of plasmids for TX-TL experiment to correlate with the
plasmids that have pMB1 and p15A origins with similar
medium copy numbers—this may partly explain the sim-
ilar results observed in the aptamer-mediated T7 RNAP
repression in vitro and in vivo (≈8-fold vs. ≈5-fold repres-
sion). Together with growing appreciation of the need for
testbed in synthetic biology [55, 56, 57], the detailed char-
acterization of cell-free expression platform may provide
an easy-to-use breadboard to expedite implementation of
synthetic biology circuits in vivo. For in vivo charac-
terization, E. coli MGZ1 cells displayed reasonably high
deGFP output even without IPTG induction—this could
be due to a weak repression of T7 RNAP expression or a
leakage from the medium-copy plasmid, considering that
even a small amount of T7 RNAP is sufficient to direct
high-level transcription from a T7 promoter. Neverthe-
less, when cells were induced with IPTG, higher deGFP
output was obtained, and repression was observed as ex-
pected when induced with aTc (except when IPTG in-
duction was very strong, possibly exceeding the expres-
sion level of T7 RNAP aptamer). Utilizing a stronger
inducible promoter and improving stability of RNA ap-
tamer using tRNA scaffold [58] or hairpins [59] may in-
crease the dynamic range provided by T7 RNAP aptamer.
A number of straightforward extensions could be im-
plemented for a broad application of the T7 RNAP ap-
tamer. Synthetic circuitry with another aptamer against
RNAP, e.g., an aptamer against SP6 RNAP [60], could
be utilized to design a synthetic bistable system or oscil-
lators [61, 62]. It is also possible to utilize an antisense
signal for T7 RNAP aptamer to produce adaptation be-
havior [51, 63]. Although widely adapted for gene ex-
pression in vivo, T7 RNAP due to its very strong tran-
scriptional activity can cause growth arrest and toxicity
when strongly induced. Analogous to recent studies uti-
lizing RNA aptamers for quantitation of mRNA [54, 64],
concatenation of T7 RNAP aptamer at the 3′ end of an
mRNA driven by T7 promoter can provide a necessary
negative feedback to regulate the expression levels of tar-
get genes, thereby reducing toxicity upon T7 RNAP in-
duction in vivo. An intriguing possibility that remains
to be tested is whether the T7 RNAP aptamer can pro-
vide differential regulation of recently reported synthetic
T7 RNAP variants with different promoter specificity [42,
43].
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Supplementary Information
Methods
The sequence of DNA oligonucleotides and RNA outputs used for in vitro transcription experiments are listed as
follows.
DNA sequences
pT3-T7apt-nt (77mer), 5′-AAGCAAGGGTAAGATGGAATGAAATTAACCCTCACTAAAGGCGAGCGTAAGTCAATTCCACTATCATTG-
CTGCAAGC-3′.
pT3-T7apt-t (49mer), 5′-GCTTGCAGCAATGATAGTGGAATTGACTTACGCTCGCCTTTAGTGAGGG-3′.
pT3-T7apt-v2-nt (83mer), 5′-AAGCAAGGGTAAGATGGAATGAAATTAACCCTCACTAAAGGCGAGCGTAAGTCAATTCCACTATCAT-
TGCTGCTTGCCTCGAG-3′.
pT3-T7apt-v2-t (55mer), 5′-CTCGAGGCAAGCAGCAATGATAGTGGAATTGACTTACGCTCGCCTTTAGTGAGGG-3′.
pT3-MGapt-nt (84mer), 5′-AAGCAAGGGTAAGATGGAATGAAATTAACCCTCACTAAAGGACAAGCATCCCGACTGGCGAGAGCCAG-
GTAACGAATGGATGCG-3′.
pT3-MGapt-t (56mer), 5′-CGCATCCATTCGTTACCTGGCTCTCGCCAGTCGGGATGCTTGTCCTTTAGTGAGGG-3′.
pT7-MGapt-nt (84mer), 5′-CTAATGAACTACTACTACACACTAATACGACTCACTATAGGACAAGCATCCCGACTGGCGAGAGCCAGG-
TAAC-GAATGGATGCG-3′.
pT7-MGapt-t (57mer), 5′-CGCATCCATTCGTTACCTGGCTCTCGCCAGTCGGGATGCTTGTCCTATAGTGAGTCG-3′.
A2-T3 (36mer), 5′-TTAATTTCATTCCATCTTACCCTTGCTTCAATCCGT-3′.
A1-T7 (35mer), 5′-TATTAGTGTGTAGTAGTAGTTCATTAGTGTCGTTC-3′.
RNA output sequences
T7apt (38mer), 5′-GGCGAGCGUAAGUCAAUUCCACUAUCAUUGCUGCAAGC-3′.
T7apt-v2 (44mer), 5′-GGCGAGCGUAAGUCAAUUCCACUAUCAUUGCUGCUUGCCUCGAG-3′.
MGapt (45mer), 5′-GGACAAGCAUCCCGACUGGCGAGAGCCAGGUAACGAAUGGAUGCG-3′.
The sequence of DNA oligonucleotides used for cloning and Gibson assembly are listed as follows.
Target Constructs Plasmids Primers
pTet-T7apt pTet-deGFP Fwd: ggcgagcgtaagtcaattccactatcattgctgcaagcctcgagAACTTTAAGAAGGAGA-
TATACCA
Rev: gcttgcagcaatgatagtggaattgacttacgctcgccTGTGCTCAGTATCTCTATCAC
pdeGFP-T7apt pTara Fwd: tcaggtgctacatttgaagaCACTTATTCAGGCGTAGCAC
Rev: atagtgagtcgtattagaacAACATGAGCAGATCCTCTACG
pT7-deGFP Fwd: gtagaggatctgctcatgttGTTCTAATACGACTCACTATAGG
Rev: atctctatcactgatagggaTTACCGCCTTTGAGTGAGCT
pTet-T7apt Fwd: agctcactcaaaggcggtaaTCCCTATCAGTGATAGAGATTG
Rev: gtgctacgcctgaataagtgTCTTCAAATGTAGCACCTGAAG
pdeGFP-T7apt-4A pdeGFP-T7apt Fwd: aaaaTGCAAGCCTCGAGCAAAGCCC
Rev: TGATAGTGGAATTGACTTACGCTCGC
pdeGFP-T7apt-4G pdeGFP-T7apt Fwd: ggggTGCAAGCCTCGAGCAAAGCCC
Rev: TGATAGTGGAATTGACTTACGCTCGC
pdeGFP-T7apt-4∆ pdeGFP-T7apt Fwd: TGCAAGCCTCGAGCAAAGCCC
Rev: TGATAGTGGAATTGACTTACGCTCGC
* Lower case letters indicate the parts of sequence that are different from the starting plasmids. For pTet-T7apt
plasmid, XhoI digestion and subsequent ligation was performed to remove deGFP sequence. For pdeGFP-T7apt
variant plamids, primers were 5′-phosphorylated and a subsequent quick ligation step was performed.
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ggatgctgcaattcagagcg  gcagcaagtgggggacagca  gaagacctgaccgccgcaga  gtggatgtttgacatggtga  agactatcgcaccatcagcc  
agaaaaccgaattttgctgg  gtgggctaacgatatccgcc  tgatgcgtgaacgtgacgga  cgtaaccaccgcgacatgtg  tgtgctgttcTAATACGACT  
CACTATAGGGGCTAGCGGGA  TCCCGACTggcgagagccag  gtaacgaatggatccAATAA  TTTTGTTTAACTTTAAGAAG  GAGATATAccATGGAGCTTT  
TCACTGGCGTTGTTCCCATC  CTGGTCGAGCTGGACGGCGA  CGTAAACGGCCACAAGTTCA  GCGTGTCCGGCGAGGGCGAG  GGCGATGCCACCTACGGCAA  
GCTGACCCTGAAGTTCATCT  GCACCACCGGCAAGCTGCCC  GTGCCCTGGCCCACCCTCGT  GACCACCCTGACCTACGGCG  TGCAGTGCTTCAGCCGCTAC  
CCCGACCACATGAAGCAGCA  CGACTTCTTCAAGTCCGCCA  TGCCCGAAGGCTACGTCCAG  GAGCGCACCATCTTCTTCAA  GGACGACGGCAACTACAAGA  
CCCGCGCCGAGGTGAAGTTC  GAGGGCGACACCCTGGTGAA  CCGCATCGAGCTGAAGGGCA  TCGACTTCAAGGAGGACGGC  AACATCCTGGGGCACAAGCT  
GGAGTACAACTACAACAGCC  ACAACGTCTATATCATGGCC  GACAAGCAGAAGAACGGCAT  CAAGGTGAACTTCAAGATCC  GCCACAACATCGAGGACGGC  
AGCGTGCAGCTCGCCGACCA  CTACCAGCAGAACACCCCCA  TCGGCGACGGCCCCGTGCTG  CTGCCCGACAACCACTACCT  GAGCACCCAGTCCGCCCTGA  
GCAAAGACCCCAACGAGAAG  CGCGATCACATGGTCCTGCT  GGAGTTCGTGACCGCCGCCG  GGATCTAActcgagctagca  taaccccttggggcctctaa  
acgggtcttgaggggttttt  tggtcgaccgatgcccttga  gagccttcaacccagtcagc  tccttccggtgggcgcgggg  catgactatcgtcgccgcac  
ttatgactgtcttctttatc  atgcaactcgtaggacaggt  gccggcagcgctcttccgct  tcctcgctcactgactcgct  gcgctcggtcgttcggctgc  
ggcgagcggtatcagctcac  tcaaaggcggtaatacggtt  atccacagaatcaggggata  acgcaggaaagaacatgtga  gcaaaaggccagcaaaaggc  
caggaaccgtaaaaaGGCCG  CGTTGCTGGCGTTTTTCCAT  AGGCTCCGCCCCCCTGACGA  GCATCACAAAAATCGACGCT  CAAGTCAGAGGTGGCGAAAC  
CCGACAGGACTATAAAGATA  CCAGGCGTTTCCCCCTGGAA  GCTCCCTCGTGCGCTCTCCT  GTTCCGACCCTGCCGCTTAC  CGGATACCTGTCCGCCTTTC  
TCCCTTCGGGAAGCGTGGCG  CTTTCTCAATGCTCACGCTG  TAGGTATCTCAGTTCGGTGT  AGGTCGTTCGCTCCAAGCTG  GGCTGTGTGCACGAACCCCC  
CGTTCAGCCCGACCGCTGCG  CCTTATCCGGTAACTATCGT  CTTGAGTCCAACCCGGTAAG  ACACGACTTATCGCCACTGG  CAGCAGCCACTGGTAACAGG  
ATTAGCAGAGCGAGGTATGT  AGGCGGTGCTACAGAGTTCT  TGAAGTGGTGGCCTAACTAC  GGCTACACTAGAAGGACAGT  ATTTGGTATCTGCGCTCTGC  
TGAAGCCAGTTACCTTCGGA  AAAAGAGTTGGTAGCTCTTG  ATCCGGCAAACAAACCACCG  CTGGTAGCGGTGGTTTTTTT  GTTTGCAAGCAGCAGATTAC  
GCGCAGAAAAAAAGGATCTC  AAGAAGATCCTTTGATCTTT  TCTAcggggtctgacgctca  gtggaacgaaaactcacgtt  aagggattttggtcatgaga  
ttatcaaaaaggatcttcac  ctagatccttttaaattaaa  aatgaagttttaaatcaatc  taaagtatatatgagtaaac  ttggtctgacagTTACCAAT  
GCTTAATCAGTGAGGCACCT  ATCTCAGCGATCTGTCTATT  TCGTTCATCCATAGTTGCCT  GACTCCCCGTCGTGTAGATA  ACTACGATACGGGAGGGCTT  
ACCATCTGGCCCCAGTGCTG  CAATGATACCGCGAGACCCA  CGCTCACCGGCTCCAGATTT  ATCAGCAATAAACCAGCCAG  CCGGAAGGGCCGAGCGCAGA  
AGTGGTCCTGCAACTTTATC  CGCCTCCATCCAGTCTATTA  ATTGTTGCCGGGAAGCTAGA  GTAAGTAGTTCGCCAGTTAA  TAGTTTGCGCAACGTTGTTG  
CCATTGCTACAGGCATCGTG  GTGTCACGCTCGTCGTTTGG  TATGGCTTCATTCAGCTCCG  GTTCCCAACGATCAAGGCGA  GTTACATGATCCCCCATGTT  
GTGCAAAAAAGCGGTTAGCT  CCTTCGGTCCTCCGATCGTT  GTCAGAAGTAAGTTGGCCGC  AGTGTTATCACTCATGGTTA  TGGCAGCACTGCATAATTCT  
CTTACTGTCATGCCATCCGT  AAGATGCTTTTCTGTGACTG  GTGAGTACTCAACCAAGTCA  TTCTGAGAATAGTGTATGCG  GCGACCGAGTTGCTCTTGCC  
CGGCGTCAATACGGGATAAT  ACCGCGCCACATAGCAGAAC  TTTAAAAGTGCTCATCATTG  GAAAACGTTCTTCGGGGCGA  AAACTCTCAAGGATCTTACC  
GCTGTTGAGATCCAGTTCGA  TGTAACCCACTCGTGCACCC  AACTGATCTTCAGCATCTTT  TACTTTCACCAGCGTTTCTG  GGTGAGCAAAAACAGGAAGG  
CAAAATGCCGCAAAAAAGGG  AATAAGGGCGACACGGAAAT  GTTGAATACTCATactcttc  ctttttcaatattattgaag  catttatcagggttattgtc  
tcatgagcggatacatattt  gaatgtatttagaaaaataa  acaaataggggttccgcgca  catttccccgaaaagtgcca  cctgacgtctaagaaaccat  
tattatcatgacattaacct  ataaaaataggcgtatcacg  aggccctttcgtcttcaaga  attctggcgaatcctctgac  cagccagaaaacgacctttc  
tgtggtgaaacc 
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CAAAGCCCGCCGAAAGGCGG  GCTTTTCTGTGTCGACCGAT  GCCCTTGAGAGCCTTCAACC  CAGTCAGCTCCTTCCGGTGG  GCGCGGGGCATGACTATCGT  
CGCCGCACTTATGACTGTCT  TCTTTATCATGCAACTCGTA  GGACAGGTGCCGGCATGATA  AGCTGTCAAACATGAGAATT  
CTGACTTCAGGTGCTACATT  TGAAGAGATAAATTGCACTG  AAATCTAGAAATATTTTATC  TGATTAATAAGATGATCTTC  TTGAGATCGTTTTGGTCTGC  
GCGTAATCTCTTGCTCTGAA  AACGAAAAAACCGCCTTGCA  GGGCGGTTTTTCGAAGGTTC  TCTGAGCTACCAACTCTTTG  AACCGAGGTAACTGGCTTGG  
AGGAGCGCAGTCACCAAAAC  TTGTCCTTTCAGTTTAGCCT  TAACCGGCGCATGACTTCAA  GACTAACTCCTCTAAATCAA  TTACCAGTGGCTGCTGCCAG  
TGGTGCTTTTGCATGTCTTT  CCGGGTTGGACTCAAGACGA  TAGTTACCGGATAAGGCGCA  GCGGTCGGACTGAACGGGGG  GTTCGTGCATACAGTCCAGC  
TTGGAGCGAACTGCCTACCC  GGAACTGAGTGTCAGGCGTG  GAATGAGACAAACGCGGCCA  TAACAG
GGAGAGCGCACGAGGGAGCC  GCCAGGGGAAACGCCTGGTA  TCTTTATAGTCCTGTCGGGT  TTCGCCACCACTGATTTGAG  CGTCAGATTTCGTGATGCTT  
GTCAGGGGGGCGGAGCCTAT  GGAAAAACGGCTTTGCCGCG  GCCCTCTCACTTCCCTGTTA  AGTATCTTCCTGGCATCTTC  CAGGAAATCTCCGCCCCGTT
CGTAAGCCATTTCCGCTCGC  CGCAGTCGAACGACCGAGCG  TAGCGAGTCAGTGAGCGAGG  AAGCGGAATATATCCTGTAT  CACATATTCTGCTGACGCAC  
CGGTGCAGCCTTTTTTCTCC  TGCCACATGAAGCACTTCAC  TGACACCCTCATCAGTGCCA  ACATAGTAAGCCAGTATACA  CTCCGCTAG
TATCAAAAAGGATCTTCACC  TAGATCCTTTTAAATTAAAA  ATGAAGTTTTAAATCAATCT  AAAGTATATATGAGTAAACT  TGGTCTGACAG
CTTAATCAGTGAGGCACCTA  TCTCAGCGATCTGTCTATTT  CGTTCATCCATAGTTGCCTG  ACTCCCCGTCGTGTAGATAA  CTACGATACGGGAGGGCTTA  
CCATCTGGCCCCAGTGCTGC  AATGATACCGCGAGACCCAC  GCTCACCGGCTCCAGATTTA  TCAG
GTGGTCCTGCAACTTTATCC  GCCTCCATCCAGTCTATTAA  TTGTTGCCGGGAAGCTAGAG  TAAGTAGTTCGCCAGTTAAT  AGTTTGCGCAACGTTGTTGC  
CATTGCTACAGGCATCGTGG  TGTCACGCTCGTCGTTTGGT  ATGGCTTCATTCAGCTCCGG  TTCCCAACGATCAAGGCGAG  TTACATGATCCCCCATGT
TGCAAAAAAGCGGTTAGCTC  CTTCGGTCCTCCGATCGTTG  TCAGAAGTAAGTTGGCCGCA  GTGTTATCACTCATGGTTAT  GGCAGCACTGCATAATTCTC  
TTACTGTCATGCCATCCGTA  AGATGCTTTTCTGTGACTGG  TGAGTACTCAACCAAGTCAT  TCTGAGAATAGTGTATGCGG  CGACCGAGTTGCTCTTGCCC  
GGCGTCAATACGGGATAATA  CCGCGCCACATAGCAGAACT  TTAAAAGTGCTCATCATTGG  AAAACGTTCTTCGGGGCGAA  AACTCTCAAGGATCTTACCG  
CTGTTGAGATCCAGTTCGAT  GTAACCCACTCGTGCACCCA  ACTGATCTTCAGCATCTTTT  ACTTTCACCAGCGTTTCTGG  GTGAGCAAAAACAGGAAGGC  
AAAATGCCGCAAAAAAGGGA  ATAAGGGCGACACGGAAATG  TTGAATACTCAT
CATGAGCGGATACATATTTG  AATGTATTTAGAAAAATAAA  CAAATAGGGGTTCCGCGCAC  ATTTCCCCGAAAAGTGCCAC  CTGACGTCTAAGAAACCATT  
ATTATCATGACATTAACCTA  TAAAAATAGGCGTATCACGA  GGCCCTTTCGTCTTCAAGAA  TTCTGGCGAATCCTCTGACC  AGCCAGAAAACGACCT
GTGGTGAAACCGGATGCTGC  AATTCAGAGCGGCAGCAAGT  GGGGGACAGCAGAAGACCTG  ACCGCCGCAGAGTGGATGTT  TGACATGGTGAAGACTATCG  
CACCATCAGCCAGAAAACCG  AATTTTGCTGGGTGGGCTAA  CGATATCCGCCTGATGCGTG  AACGTGACGGACGTAACCAC  CGCGACATGTGTGTGCTGTT  
CCCTAT  CAGTGATAGAGATTGACATC  CCTATCAGTGATAGAGATAC  TGAGCACA
GCAAGCCTCGAG
01                    21                    41                    61                    81   
ACAACTTATATCGTATGGGG  
CGGAATGACACCGG  TAAACCGAAAGGCAGGAACA  
  
GGTCATGAGAT  
TTACCAATG  
CAATAAACCAGCCAGC  CGGAAGGGCCGAGCGCAGAA  
TG  
ACTCTTCC  TTTTTCAATATTATTGAAGC  ATTTATCAGGGTTATTGTCT  
TTCT  
CCGCTGGGCATGCT GGCGAGCGTAAG  TCAATTCCACTATCATTGCT  
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Figure S1: Plasmid maps. Plasmid pT7-deGFP was derived from the plasmid pIVEX2.3d (Roche) [38]. Plasmid pTet-
T7apt was constructed using Gibson assembly method with plasmid pBEST-Luc (Promega) as a backbone. Plasmid pTara
was used as a backbone to join pT7-deGFP and pTet-aptamer expression cassettes in plasmid pdeGFP-T7apt.
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cacttattcaggcgtagcac  caggcgtttaagggcaccaa  taactgccttaaaaaaa
TTAAGCATTCTGCCGACATG  GAAGCCATCACAGACGGCAT  GATGAACCTGAATCGCCAGC  GGCATCAGCACCTTGTCGCC  TTGCGTATAATATTTGCCCA  
TGGTGAAAACGGGGGCGAAG  AAGTTGTCCATATTGGCCAC  GTTTAAATCAAAACTGGTGA  AACTCACCCAGGGATTGGCT  GAGACGAAAAACATATTCTC  
AATAAACCCTTTAGGGAAAT  AGGCCAGGTTTTCA
CAGAGCGATGAAAACGTTTC  AGTTTGCTCATGGAAAACGG  TGTAACAAGGGTGAACACTA  TCCCATATCACCAGCTCACC  GTCTTTCATTGCCATACGGA  
ATTCCGGATGAGCATTCATC  AGGCGGGCAAGAATGTGAAT  AAAGGCCGGATAAAACTTGT  GCTTAT
CAGCTGAACGGTCTGGTTAT  AGGTACATTGAGCAACTGAC  TGAAATGCCTCAAAATGTTC  TTTACGATGCCATTGGGATA  TATCAACGGTGGTATATCCA  
tttt  agcttccttagctcctgaaa  atctcgataactcaaaaaat  acgcccggtagtgatcttat  ttcattatggtgaaagttgg
aacctcttacgtgccgatca  acgtctcattttcgccaaaa  gttggcccagggcttcccgg  tatcaacagggacaccagga  tttatttattctgcgaagtg  
atcttccgtcacaggtattt  attcggcgcaaagtgcgtcg  ggtgatgctgccaacttact  gatttagtgtatgatggtgt  ttttgaggtgctccagtggc  
ttctgtttctatcagctgtc  cctcctgttcag
cttactatgttggcactgat  gagggtgtcagtgaagtgct  tcatgtggcaggagaaaaaa  ggctgcaccggtgcgtcagc  agaatatgtgatacaggata  
tattccgcttcctcgctcac  tgactcgctacgctcggtcg  ttcgactgcggcgagcggaa  atgg
ggaagatacttaacagggaa  gtgagagggccgcggcaaag  ccgtt
TGGTGGCGAAACCCGACAGG  ACTATAAAGATACCAGGCGT  TTCCCCCTGGCGGCTCCCTC  GTGCGCTCTCCTGTTCCTGC  CTTTCGGTTTACCGGTGT
TTCCGCTGTTATGGCCGCGT  TTGTCTCATTCCACGCCTGA  CACTCAGTTCCGGGTAGGCA  GTTCGCTCCAAGCTGGACTG  TATGCACGAACCCCCCGTTC  
AGTCCGACCGCTGCGCCTTA  TCCGGTAACTATCGTCTTGA  GTCCAACCCGGAAAGACATG  CAAAAGCACCACTGGCAGCA  GCCACTGGTAATTGATTTAG  
AGGAGTTAGTCTTGAAGTCA  TGCGCCGGTT
GGTAGCTCAGAGAACCTTCG  AAAAACCGCCCTGCAAGGCG  GTTTTTTCGTTTTCAGAGCA  AGAGATTACGCGCAGACCAA  AACGATCTCAA
cttattaatcagataaaata  tttgctcatgagcccgaagt  ggcgagcccgatcttcccca  tc
tggcgccggtgatgccggcc  acgatgcgtccggcgtagag  gatctgctcatgttgttc
agagccaggtaacgaatgga  tccAATAATTTTGTTTAACT  TTAAGAAGGAGATATA
GACGGCGACGTAAACGGCCA  CAAGTTCAGCGTGTCCGGCG  AGGGCGAGGGCGATGCCACC  TACGGCAAGCTGACCCTGAA  GTTCATCTGCACCACCGGCA  
AGCTGCCCGTGCCCTGGCCC  ACCCTCGTGACCACCCTGAC  CTACGGCGTGCAGTGCTTCA  GCCGCTACCCCGACCACATG  AAGCAGCACGACTTCTTCAA  
GTCCGCCATGCCCGAAGGCT  ACGTCCAG
CTGGTGAACCGCATCGAGCT  GAAGGGCATCGACTTCAAGG  AGGACGGCAACATCCTGGGG  CACAAGCTGGAGTACAACTA  CAACAGCCACAACGTCTATA  
TCATGGCCGACAAGCAGAAG  AACGGCATCAAGGTGAACTT  CAAGATCCGCCACAACATCG  
CACCCCCATCGGCGACGGCC  CCGTGCTGCTGCCCGACAAC  CACTACCTGAGCACCCAGTC  CGCCCTGAGCAAAGACCCCA  ACGAGAAGCGCGATCACATG  
GTCCTGCTGGAGTTCGTGAC  CGCCGCCGGGATCTAA
gcccttgagagccttcaacc  cagtcagctccttccggtgg  gcgcggggcatgactatcgt  cgccgcacttatgactgtct  tctttatcatgcaactcgta  
ggacaggtgccggcagcgct  cttccgcttcctcgctcact  gactcgctgcgctcggtcgt  tcggctgcggcgagcggtat  cagctcactcaaaggcggta  
CCCTATCAGTGATAGAGA  TTGACA
CAAAGCCCGCCGAAAGGCGG  GCTTTTCTGT
cgccgcacttatgactgtct  tctttatcatgcaactcgta  ggacaggtgccggcatgata
ctgacttcaggtgctacatt  tgaaga
                    21                    41                    61                    81  
TTA  CGCCCCGCCCTGCCACTCAT  CGCAGTACTGTTGTAATTCA  
CCGTAA  CACGCCACATCTTGCGAATA  TATGTGTAGAAACTGCCGGA  AATCGTCGTGGTATTCACTC  
TTTTCTTTACGGTC  TTTAAAAAGGCCGTAATATC  
GTGATTTTTTTCTCCA   
ctactgac  ggggtggtgcgtaacggcaa  aagcaccgccggacatcagc  gctagcggagtgtatactgg  
cttacgaacggggcgg  agatttcctggaagatgcca  
TTTCCATAGGCTCCG  CCCCCCTGACAAGCATCACG  AAATCTGACGCTCAAATCAG  
CA  
AAGGCTAAAC  TGAAAGGACAAGTTTTGGTG  ACTGCGCTCCTCCAAGCCAG  TTACCTCGGTTCAAAGAGTT  
gaagatcat  
ggtgatgtcggcgatata  ggcgccagcaaccgcacctg  
TA  ATACGACTCACTATAGGGGC  TAGCGGGATCCCGACTggcg  
ccAT  GGAGCTTTTCACTGGCGTTG  TTCCCATCCTGGTCGAGCTG  
GAGCGCACCATC  TTCTTCAAGGACGACGGCAA  CTACAAGACCCGCGCCGAGG  TGAAGTTCGAGGGCGACACC  
AGGACGGCAGCGTGCAGCTC  GCCGACCACTACCAGCAGAA  
ctcg  agCTAGCATAACCCCTTGGG  GCCTCTAAACGGGTCTTGAG  GGGTTTTTTGgtcgaccgat  
at TCCCTATCAGTGAT  AGAGATACTGAGCACAGGCG  AGCGTAAGTCAATTCCACTA  TCATTGCTGCAAGCCTCGAG  
gtcgaccgat  gcccttgagagccttcaacc  cagtcagctccttccggtgg  gcgcggggcatgactatcgt  
  agctgtcaaacatgagaatt  acaacttatatcgtatgggg  
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Figure S2: Spectrofluorometer analysis of T7 RNAP aptamer in in vitro transcription circuits. (A) With pT3-MGapt
template in a transcription buffer in a cuvette, T3 RNAP was added at 10 min. MG aptamer was not produced until the
activator A2 was added at 25 min, indicating that the incomplete promoter design also works for T3 promoter much as T7
promoter design used for genelet circuits. (B) Close-up of the timecourse experiment shown in Figure 1C. The activator
A2 was added at 40 min. The ‘input A2’ trajectories began to diverge from ‘no input A2’ trajectories about 10 min after
the introduction of input A2. (C) Test of modified aptamer against T7 RNAP (T7apt-v2). Here, pT3-T7apt-v2 template
was used instead of pT3-T7apt. The two RNA polymerases were added at 10 min, the input A1 was added at 25 min, and
the input A2 was added at 45 min following the protocols used in Figure 1C. The T7apt-v2 was efficient in repressing the
T7 RNAP activity; about 3-fold decrease in MGapt signal was observed over 1.5 hours in the presence of the T7apt-v2.
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Figure S3: Genetic circuits and aptamer-mediated T7 RNAP inhibition in the TX-TL system. (A) Designed circuit for
in vivo experiments. (B) Three-plasmid system used for aptamer-mediated T7 RNAP inhibition test in the TX-TL cell-
free extract. (C) Experimental results showed that T7 RNAP was induced by IPTG to express deGFP and that deGFP
expression was decreased by 8 fold in the presence of T7 RNAP aptamer expressing plasmid pTet-T7apt. The T7 RNAP
aptamer production was not inhibited by TetR since the cell extract does not contain TetR protein. The fluorescence signal
from deGFP were measured at 4 hrs.
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Figure S4: Plate reader analysis of T7 RNAP aptamer and variants in vivo. (A) Time course of GFP/OD measurements
in LB/1% glucose media as reported in Figure 3B left panel. The GFP/OD values decreased over time as the cells reached
stationary phase after 6 hrs. However, the relative ratio of GFP/OD values for different aTc induction levels did not vary
considerably during the 6 to 10 hr time window. (B) The response curve of T7 RNAP aptamer and its variants upon
aTc induction in LB media. (C) The response curve of T7 RNAP aptamer and its variants upon aTc induction in LB
media with 10 µM IPTG. (D) The response curve of T7 RNAP aptamer upon aTc induction in LB/1% glucose media with
different levels of IPTG. At high IPTG level, the response to aTc induction was abolished. This set of data is represented
as a heat map in Figure 3B right panel. GFP/OD values were measured after 8 hrs for (B–D).
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Figure S5: Flow cytometry analysis of mutant T7 RNAP aptamer in vivo. One of the replicate GFP histogram (50,000
events) for (A) T7apt-4A, (B) T7apt-4G, (C) T7apt-4∆. The GFP expression levels did not change upon induction of
T7 RNAP aptamer by aTc for all mutant aptamers. The modal GFP values are plotted in Figure 3C.
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